Michael J Campa

4PUBLICATIONS
23CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 28, 2026
Tumor-Derived Complement C3 Overexpression in STK11-Mutant Lung Adenocarcinoma Drives Tumor Growth and Immune Checkpoint Inhibitor Resistance.

|Jan 03, 2025
Complement factor H targeting antibody GT103 in refractory non-small cell lung cancer: a phase 1b dose escalation trial.

Jeffrey M Clarke, George R Simon, Hirva Mamdani

|Apr 01, 2024
Promotion of an Antitumor Immune Program by a Tumor-specific, Complement-activating Antibody.

Ruchi Saxena, Ryan T Bushey, Michael J Campa

|Mar 30, 2023
Antitumor Immune Mechanisms of the Anti-Complement Factor H Antibody GT103.

Ryan T Bushey, Ruchi Saxena, Michael J Campa

Pageof 1

Frequent Collaborators

4 joint publications

Elizabeth B Gottlin

4 joint publications

Edward F Patz

3 joint publications

Ruchi Saxena

3 joint publications

You-Wen He